title: Cellular transplantation-based evolving treatment options in spinal cord injury.
abstract: Spinal cord injury (SCI) often represents a condition of permanent neurologic deficit. It has been possible to understand and delineate the mechanisms contributing to loss of function following primary injury. The clinicians might hope to improve the outcome in SCI injury by designing treatment strategies that could target these secondary mechanisms of response to injury. However, the approaches like molecular targeting of the neurons or surgical interventions have yielded very limited success till date. In recent times, a great thrust is put on to the cellular transplantation mode of treatment strategies to combat SCI problems so as to gain maximum functional recovery. In this review, we discuss about the various cellular transplantation strategies that could be employed in the treatment of SCI. The success of such cellular approaches involving Schwann cells, olfactory ensheathing cells, peripheral nerve, embryonic CNS tissue and activated macrophage has been supported by a number of reports and has been detailed here. Many of these cell transplantation strategies have reached the clinical trial stages. Also, the evolving field of stem cell therapy has made it possible to contemplate the role of both embryonic stem cells and induced pluripotent stem cells to stimulate the differentiation of neurons when transplanted in SCI models. Moreover, the roles of tissue engineering techniques and synthetic biomaterials have also been explained with their beneficial and deleterious effects. Many of these cell-based therapeutic approaches have been able to cause only a little change in recovery and a combinatorial approach involving more than one strategy are now being tried out to successfully treat SCI and improve functional recovery.
authors.affiliation: Department of Osteology, Affiliated Hospital of Yanbian University, Yanji, Jilin, China.
authors.forename: Mao-cheng
authors.initials: MC
authors.lastname: Wu
authors.forename: Hu
authors.initials: H
authors.lastname: Yuan
authors.forename: Kang-jie
authors.initials: KJ
authors.lastname: Li
authors.forename: De-Lai
authors.initials: DL
authors.lastname: Qiu
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology; D017690:Cell Transplantation / Q000379:methods*; D006801:Humans; D009414:Nerve Growth Factors / Q000494:pharmacology; D013119:Spinal Cord Injuries / Q000473:pathology / Q000628:therapy*; D023822:Tissue Engineering
chemical_list: D001672:Biocompatible Materials; D009414:Nerve Growth Factors